Qiong-Cong Xu

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

Oncogene

This page only lists publications with an associated author ORCID identifier.

Publications

Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, Ying-Qin Zhu, Guang-Yin Zhao, Jing-Yuan Ye, Fu-Xi Li, Xi-Tai Huang, Xi-Yu Wang, Jie-Qin Wang, Qiong-Cong Xu, Xiao-Yu Yin
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene 43 (31) (2024)
Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, Ying-Qin Zhu, Guang-Yin Zhao, Jing-Yuan Ye, Fu-Xi Li, Xi-Tai Huang, Xi-Yu Wang, Jie-Qin Wang, Qiong-Cong Xu, Xiao-Yu Yin
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene (2024)
Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, Ying-Qin Zhu, Guang-Yin Zhao, Jing-Yuan Ye, Fu-Xi Li, Xi-Tai Huang, Xi-Yu Wang, Jie-Qin Wang, Qiong-Cong Xu, Xiao-Yu Yin
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene 43 (31) (2024)
Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, Ying-Qin Zhu, Guang-Yin Zhao, Jing-Yuan Ye, Fu-Xi Li, Xi-Tai Huang, Xi-Yu Wang, Jie-Qin Wang, Qiong-Cong Xu, Xiao-Yu Yin
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene 43 (31) (2024)
Ming-Jian Ma, Yin-Hao Shi, Zhi-De Liu, Ying-Qin Zhu, Guang-Yin Zhao, Jing-Yuan Ye, Fu-Xi Li, Xi-Tai Huang, Xi-Yu Wang, Jie-Qin Wang, Qiong-Cong Xu, Xiao-Yu Yin
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene 43 (31) (2024)
Qiong-Cong Xu, Yi-Chih Tien, Yin-Hao Shi, Siyun Chen, Ying-Qin Zhu, Xi-Tai Huang, Chen-Song Huang, Wei Zhao, Xiao-Yu Yin
METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m 6 A-YTHDF2-dependent manner. Oncogene 41 (11) (2022)

Qiong-Cong Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qiong-Cong Xu